Sao Paulo to shut bars and shops as pandemic snowballs; more infectious variants spark new rise in cases in Serbia
Dutch Covid test centre hit by suspected bomb attack German doctors broach ‘taboo’ subject of Covid toll on minority groups UK unions attack ‘sinister’ plan to force NHS staff to have vaccine Brazil Covid outbreak is global threat that opens door to lethal variantsSee all our coronavirus coverage
5.40pm GMT
Indian pharmaceutical company Bharat Biotech has said its Covid-19 vaccine is almost 81% effective at preventing infection following interim phase 3 trials.
Health officials approved the firm’s Covaxin jab for emergency use in January despite its phase 3 trials - the last stage before regulatory approval - not being complete, AFP reports.
“Covaxin (not only) demonstrates high clinical efficacy trend against Covid-19 but also significant immunogenicity against the rapidly emerging variants.”
5.27pm GMT
German doctors are reportedly concerned about the large proportion of people from minority ethnic backgrounds among coronavirus patients in intensive care, citing a lack of proper communication with Muslim communities in particular about the dangers of the disease.
Lothar Wieler, the head of the Robert Koch Institute, Germany’s disease control agency, confirmed that the issue was discussed with senior medical consultants last month, though he stressed the meeting was informal.
Related: German doctors broach ‘taboo’ subject of Covid toll on minority groups
Continue reading....png)
5 months ago
79
